Try our Advanced Search for more refined results

October 27, 2022

AbbVie Inc. et al v. Alkem Laboratories Limited et al

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.

Coverage

  1. October 28, 2022

    Sandoz, Teva, Others Face AbbVie Drug Patent Battle

    AbbVie has slapped rival drugmakers including Sandoz and Teva with a patent suit in Delaware federal court over its brand-name endometriosis medication Orilissa, arguing that the accused rivals are jumping the gun on a generic version of the high-earning treatment.

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

View the parties now

Already a subscriber? Click here to login